Camlin Fine Sciences plans to set up a wholly owned subsidiary in Canada for undertaking trading and distribution of antioxidants, food ingredients, blends and formulations in the US and Canadian markets. The company, however, did not disclose financial details or any other information about the proposed subsidiary. The stock on Monday closed three per cent lower at ₹22.65.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.